Literature DB >> 20079660

Prostaglandins in bone: bad cop, good cop?

Katherine A Blackwell1, Lawrence G Raisz, Carol C Pilbeam.   

Abstract

Prostaglandins (PGs) are multifunctional regulators of bone metabolism that stimulate both bone resorption and formation. PGs have been implicated in bone resorption associated with inflammation and metastatic bone disease, and also in bone formation associated with fracture healing and heterotopic ossification. Recent studies have identified roles for inducible cyclooxygenase (COX)-2 and PGE(2) receptors in these processes. Although the effects of PGs have been most often associated with cAMP production and protein kinase A activation, PGs can engage an extensive G-protein signaling network. Further analysis of COX-2 and PG receptors and their downstream G-protein signaling in bone could provide important clues to the regulation of skeletal cell growth in both health and disease. 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20079660      PMCID: PMC2862787          DOI: 10.1016/j.tem.2009.12.004

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  75 in total

1.  Comparison of the action of transient and continuous PTH on primary osteoblast cultures expressing differentiation stage-specific GFP.

Authors:  Yu-Hsiung Wang; Yaling Liu; Kathy Buhl; David W Rowe
Journal:  J Bone Miner Res       Date:  2004-10-25       Impact factor: 6.741

2.  Biphasic effect of prostaglandin E2 on osteoclast formation in spleen cell cultures: role of the EP2 receptor.

Authors:  Katsuhiro Ono; Hironori Kaneko; Shilpa Choudhary; Carol C Pilbeam; Joseph A Lorenzo; Takuhiko Akatsu; Nobuo Kugai; Lawrence G Raisz
Journal:  J Bone Miner Res       Date:  2004-10-25       Impact factor: 6.741

3.  Patent ductus arteriosus and neonatal death in prostaglandin receptor EP4-deficient mice.

Authors:  E Segi; Y Sugimoto; A Yamasaki; Y Aze; H Oida; T Nishimura; T Murata; T Matsuoka; F Ushikubi; M Hirose; T Tanaka; N Yoshida; S Narumiya; A Ichikawa
Journal:  Biochem Biophys Res Commun       Date:  1998-05-08       Impact factor: 3.575

4.  Prostaglandins: stimulation of bone resorption in tissue culture.

Authors:  D C Klein; L G Raisz
Journal:  Endocrinology       Date:  1970-06       Impact factor: 4.736

5.  Prostaglandin E2 receptor (EP4) selective agonist (ONO-4819.CD) accelerates bone repair of femoral cortex after drill-hole injury associated with local upregulation of bone turnover in mature rats.

Authors:  Masahiro Tanaka; Akinori Sakai; Soshi Uchida; Shinya Tanaka; Masato Nagashima; Teruaki Katayama; Kojiro Yamaguchi; Toshitaka Nakamura
Journal:  Bone       Date:  2004-06       Impact factor: 4.398

6.  Congenital lack of COX-2 affects mechanical and geometric properties of bone in mice.

Authors:  Q Chen; J Y Rho; Z Fan; S J F Laulederkind; R Raghow
Journal:  Calcif Tissue Int       Date:  2003-07-24       Impact factor: 4.333

7.  Stimulation of cAMP production and cyclooxygenase-2 by prostaglandin E(2) and selective prostaglandin receptor agonists in murine osteoblastic cells.

Authors:  Yoko Sakuma; Ziaodong Li; Carol C Pilbeam; Cynthia B Alander; Daichi Chikazu; Hiroshi Kawaguchi; Lawrence G Raisz
Journal:  Bone       Date:  2004-05       Impact factor: 4.398

8.  Rescue of female infertility from the loss of cyclooxygenase-2 by compensatory up-regulation of cyclooxygenase-1 is a function of genetic makeup.

Authors:  Haibin Wang; Wen-ge Ma; Lovella Tejada; Hao Zhang; Jason D Morrow; Sanjoy K Das; Sudhansu K Dey
Journal:  J Biol Chem       Date:  2003-12-29       Impact factor: 5.157

9.  A natural disruption of the secretory group II phospholipase A2 gene in inbred mouse strains.

Authors:  B P Kennedy; P Payette; J Mudgett; P Vadas; W Pruzanski; M Kwan; C Tang; D E Rancourt; W A Cromlish
Journal:  J Biol Chem       Date:  1995-09-22       Impact factor: 5.157

10.  Prostaglandin E2 activates outwardly rectifying Cl(-) channels via a cAMP-dependent pathway and reduces cell motility in rat osteoclasts.

Authors:  Fujio Okamoto; Hiroshi Kajiya; Hidefumi Fukushima; Eijiro Jimi; Koji Okabe
Journal:  Am J Physiol Cell Physiol       Date:  2004-03-24       Impact factor: 4.249

View more
  84 in total

1.  In vivo effects of two novel ALN-EP4a conjugate drugs on bone in the ovariectomized rat model for reversing postmenopausal bone loss.

Authors:  S Hu; C C Liu; G Chen; T Willett; R N Young; M D Grynpas
Journal:  Osteoporos Int       Date:  2015-08-14       Impact factor: 4.507

Review 2.  Targeting polymer therapeutics to bone.

Authors:  Stewart A Low; Jindřich Kopeček
Journal:  Adv Drug Deliv Rev       Date:  2012-01-28       Impact factor: 15.470

3.  Osteoclasts and hematopoiesis.

Authors:  Anna Teti
Journal:  Bonekey Rep       Date:  2012-03-28

4.  Pro-inflammatory M1 macrophages promote Osteogenesis by mesenchymal stem cells via the COX-2-prostaglandin E2 pathway.

Authors:  Laura Y Lu; Florence Loi; Karthik Nathan; Tzu-Hua Lin; Jukka Pajarinen; Emmanuel Gibon; Akira Nabeshima; Luis Cordova; Eemeli Jämsen; Zhenyu Yao; Stuart B Goodman
Journal:  J Orthop Res       Date:  2017-03-13       Impact factor: 3.494

Review 5.  The osteocyte: an endocrine cell ... and more.

Authors:  Sarah L Dallas; Matthew Prideaux; Lynda F Bonewald
Journal:  Endocr Rev       Date:  2013-04-23       Impact factor: 19.871

6.  Celecoxib treatment of fibrous dysplasia (FD) in a human FD cell line and FD-like lesions in mice with protein kinase A (PKA) defects.

Authors:  Emmanouil Saloustros; Sisi Liu; Edward L Mertz; Nisan Bhattacharyya; Matthew F Starost; Paraskevi Salpea; Maria Nesterova; Michael Collins; Sergey Leikin; Constantine A Stratakis
Journal:  Mol Cell Endocrinol       Date:  2016-08-04       Impact factor: 4.102

7.  Mechanisms of osteoclast-dependent bone formation.

Authors:  Anna Teti
Journal:  Bonekey Rep       Date:  2013-12-04

8.  Phospholipases of mineralization competent cells and matrix vesicles: roles in physiological and pathological mineralizations.

Authors:  Saida Mebarek; Abdelkarim Abousalham; David Magne; Le Duy Do; Joanna Bandorowicz-Pikula; Slawomir Pikula; René Buchet
Journal:  Int J Mol Sci       Date:  2013-03-01       Impact factor: 5.923

9.  The cytoskeletal regulatory scaffold protein GIT2 modulates mesenchymal stem cell differentiation and osteoblastogenesis.

Authors:  Xiaojuan Wang; Shaoxi Liao; Erik R Nelson; Robert Schmalzigaug; Robert F Spurney; Farshid Guilak; Richard T Premont; Diane Gesty-Palmer
Journal:  Biochem Biophys Res Commun       Date:  2012-07-27       Impact factor: 3.575

Review 10.  cAMP/PKA signaling defects in tumors: genetics and tissue-specific pluripotential cell-derived lesions in human and mouse.

Authors:  Constantine A Stratakis
Journal:  Mol Cell Endocrinol       Date:  2013-02-26       Impact factor: 4.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.